nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—DPP9—prostate gland—prostate cancer	0.0566	0.286	CbGeAlD
Vildagliptin—DPP9—testis—prostate cancer	0.0249	0.126	CbGeAlD
Vildagliptin—DPP4—prostate gland—prostate cancer	0.0217	0.109	CbGeAlD
Vildagliptin—DPP4—seminal vesicle—prostate cancer	0.0183	0.0925	CbGeAlD
Vildagliptin—DPP9—lymph node—prostate cancer	0.0181	0.0914	CbGeAlD
Vildagliptin—DPP4—epithelium—prostate cancer	0.0159	0.0804	CbGeAlD
Vildagliptin—DPP4—renal system—prostate cancer	0.0148	0.0746	CbGeAlD
Vildagliptin—Saxagliptin—CYP3A5—prostate cancer	0.0127	0.698	CrCbGaD
Vildagliptin—DPP4—bone marrow—prostate cancer	0.0112	0.0564	CbGeAlD
Vildagliptin—DPP4—testis—prostate cancer	0.00954	0.0482	CbGeAlD
Vildagliptin—DPP4—lymph node—prostate cancer	0.00691	0.0349	CbGeAlD
Vildagliptin—Saxagliptin—CYP3A4—prostate cancer	0.00548	0.302	CrCbGaD
Vildagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—GRP—prostate cancer	0.00179	0.126	CbGpPWpGaD
Vildagliptin—DPP4—Incretin synthesis, secretion, and inactivation—GRP—prostate cancer	0.00159	0.112	CbGpPWpGaD
Vildagliptin—Asthenia—Bicalutamide—prostate cancer	0.00149	0.00193	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.00148	0.00192	CcSEcCtD
Vildagliptin—Angiopathy—Estradiol—prostate cancer	0.00146	0.0019	CcSEcCtD
Vildagliptin—Chills—Estradiol—prostate cancer	0.00144	0.00188	CcSEcCtD
Vildagliptin—Oedema—Goserelin—prostate cancer	0.00144	0.00187	CcSEcCtD
Vildagliptin—Nausea—Cabazitaxel—prostate cancer	0.00144	0.00187	CcSEcCtD
Vildagliptin—Infection—Goserelin—prostate cancer	0.00143	0.00186	CcSEcCtD
Vildagliptin—Oedema—Conjugated Estrogens—prostate cancer	0.00143	0.00186	CcSEcCtD
Vildagliptin—Infection—Conjugated Estrogens—prostate cancer	0.00142	0.00184	CcSEcCtD
Vildagliptin—Diarrhoea—Bicalutamide—prostate cancer	0.00142	0.00184	CcSEcCtD
Vildagliptin—Nervous system disorder—Goserelin—prostate cancer	0.00141	0.00184	CcSEcCtD
Vildagliptin—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.0014	0.00182	CcSEcCtD
Vildagliptin—Malnutrition—Estradiol—prostate cancer	0.0014	0.00182	CcSEcCtD
Vildagliptin—Skin disorder—Goserelin—prostate cancer	0.0014	0.00182	CcSEcCtD
Vildagliptin—Hyperhidrosis—Goserelin—prostate cancer	0.00139	0.00181	CcSEcCtD
Vildagliptin—Urticaria—Ethinyl Estradiol—prostate cancer	0.00139	0.00181	CcSEcCtD
Vildagliptin—Infestation NOS—Etoposide—prostate cancer	0.00139	0.00181	CcSEcCtD
Vildagliptin—Infestation—Etoposide—prostate cancer	0.00139	0.00181	CcSEcCtD
Vildagliptin—Skin disorder—Conjugated Estrogens—prostate cancer	0.00139	0.0018	CcSEcCtD
Vildagliptin—Liver function test abnormal—Docetaxel—prostate cancer	0.00138	0.0018	CcSEcCtD
Vildagliptin—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.00138	0.00179	CcSEcCtD
Vildagliptin—Flatulence—Estradiol—prostate cancer	0.00138	0.00179	CcSEcCtD
Vildagliptin—Dizziness—Bicalutamide—prostate cancer	0.00137	0.00178	CcSEcCtD
Vildagliptin—Chills—Mitoxantrone—prostate cancer	0.00135	0.00175	CcSEcCtD
Vildagliptin—Nasopharyngitis—Docetaxel—prostate cancer	0.00134	0.00174	CcSEcCtD
Vildagliptin—Liver function test abnormal—Capecitabine—prostate cancer	0.00134	0.00174	CcSEcCtD
Vildagliptin—Skin exfoliation—Epirubicin—prostate cancer	0.00133	0.00173	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Etoposide—prostate cancer	0.00131	0.00171	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Goserelin—prostate cancer	0.00131	0.00171	CcSEcCtD
Vildagliptin—Tremor—Estradiol—prostate cancer	0.00131	0.00171	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.0013	0.00169	CcSEcCtD
Vildagliptin—Headache—Bicalutamide—prostate cancer	0.0013	0.00169	CcSEcCtD
Vildagliptin—Nasopharyngitis—Capecitabine—prostate cancer	0.0013	0.00169	CcSEcCtD
Vildagliptin—Angioedema—Estradiol—prostate cancer	0.00128	0.00166	CcSEcCtD
Vildagliptin—Asthenia—Ethinyl Estradiol—prostate cancer	0.00126	0.00163	CcSEcCtD
Vildagliptin—Fatigue—Goserelin—prostate cancer	0.00124	0.00162	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.00123	0.0016	CcSEcCtD
Vildagliptin—Constipation—Goserelin—prostate cancer	0.00123	0.0016	CcSEcCtD
Vildagliptin—Fatigue—Conjugated Estrogens—prostate cancer	0.00123	0.0016	CcSEcCtD
Vildagliptin—Nausea—Bicalutamide—prostate cancer	0.00123	0.0016	CcSEcCtD
Vildagliptin—Skin exfoliation—Doxorubicin—prostate cancer	0.00123	0.0016	CcSEcCtD
Vildagliptin—Constipation—Conjugated Estrogens—prostate cancer	0.00122	0.00159	CcSEcCtD
Vildagliptin—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.0012	0.00156	CcSEcCtD
Vildagliptin—Arthralgia—Estradiol—prostate cancer	0.00119	0.00155	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.00118	0.00154	CcSEcCtD
Vildagliptin—Weight increased—Docetaxel—prostate cancer	0.00118	0.00153	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Capecitabine—prostate cancer	0.00117	0.00151	CcSEcCtD
Vildagliptin—Dizziness—Ethinyl Estradiol—prostate cancer	0.00116	0.00151	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Epirubicin—prostate cancer	0.00116	0.0015	CcSEcCtD
Vildagliptin—Infestation—Docetaxel—prostate cancer	0.00116	0.0015	CcSEcCtD
Vildagliptin—Infestation NOS—Docetaxel—prostate cancer	0.00116	0.0015	CcSEcCtD
Vildagliptin—Urticaria—Goserelin—prostate cancer	0.00115	0.00149	CcSEcCtD
Vildagliptin—Oedema—Estradiol—prostate cancer	0.00114	0.00149	CcSEcCtD
Vildagliptin—Weight increased—Capecitabine—prostate cancer	0.00114	0.00148	CcSEcCtD
Vildagliptin—Infection—Estradiol—prostate cancer	0.00114	0.00148	CcSEcCtD
Vildagliptin—Urticaria—Conjugated Estrogens—prostate cancer	0.00114	0.00147	CcSEcCtD
Vildagliptin—Angiopathy—Etoposide—prostate cancer	0.00113	0.00147	CcSEcCtD
Vildagliptin—Nervous system disorder—Estradiol—prostate cancer	0.00112	0.00146	CcSEcCtD
Vildagliptin—Chills—Etoposide—prostate cancer	0.00112	0.00145	CcSEcCtD
Vildagliptin—Infestation NOS—Capecitabine—prostate cancer	0.00112	0.00145	CcSEcCtD
Vildagliptin—Infestation—Capecitabine—prostate cancer	0.00112	0.00145	CcSEcCtD
Vildagliptin—Arthralgia—Mitoxantrone—prostate cancer	0.00111	0.00144	CcSEcCtD
Vildagliptin—Skin disorder—Estradiol—prostate cancer	0.00111	0.00144	CcSEcCtD
Vildagliptin—Hyperhidrosis—Estradiol—prostate cancer	0.00111	0.00144	CcSEcCtD
Vildagliptin—Headache—Ethinyl Estradiol—prostate cancer	0.0011	0.00143	CcSEcCtD
Vildagliptin—Pancreatitis—Prednisone—prostate cancer	0.0011	0.00142	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Docetaxel—prostate cancer	0.00109	0.00142	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Doxorubicin—prostate cancer	0.00107	0.00139	CcSEcCtD
Vildagliptin—Oedema—Mitoxantrone—prostate cancer	0.00107	0.00138	CcSEcCtD
Vildagliptin—Infection—Mitoxantrone—prostate cancer	0.00106	0.00138	CcSEcCtD
Vildagliptin—Dermatitis bullous—Epirubicin—prostate cancer	0.00106	0.00137	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Capecitabine—prostate cancer	0.00106	0.00137	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Estradiol—prostate cancer	0.00104	0.00135	CcSEcCtD
Vildagliptin—Nausea—Ethinyl Estradiol—prostate cancer	0.00104	0.00135	CcSEcCtD
Vildagliptin—Hepatitis—Docetaxel—prostate cancer	0.00104	0.00135	CcSEcCtD
Vildagliptin—Hypoglycaemia—Epirubicin—prostate cancer	0.00104	0.00135	CcSEcCtD
Vildagliptin—Asthenia—Goserelin—prostate cancer	0.00104	0.00134	CcSEcCtD
Vildagliptin—Skin disorder—Mitoxantrone—prostate cancer	0.00104	0.00134	CcSEcCtD
Vildagliptin—Hyperhidrosis—Mitoxantrone—prostate cancer	0.00103	0.00134	CcSEcCtD
Vildagliptin—Asthenia—Conjugated Estrogens—prostate cancer	0.00103	0.00133	CcSEcCtD
Vildagliptin—Oedema peripheral—Docetaxel—prostate cancer	0.00102	0.00133	CcSEcCtD
Vildagliptin—Connective tissue disorder—Docetaxel—prostate cancer	0.00102	0.00132	CcSEcCtD
Vildagliptin—Weight increased—Prednisone—prostate cancer	0.00102	0.00132	CcSEcCtD
Vildagliptin—Hepatitis—Capecitabine—prostate cancer	0.001	0.0013	CcSEcCtD
Vildagliptin—Oedema peripheral—Capecitabine—prostate cancer	0.000989	0.00128	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Estradiol—prostate cancer	0.000988	0.00128	CcSEcCtD
Vildagliptin—Diarrhoea—Goserelin—prostate cancer	0.000987	0.00128	CcSEcCtD
Vildagliptin—Connective tissue disorder—Capecitabine—prostate cancer	0.000987	0.00128	CcSEcCtD
Vildagliptin—Fatigue—Estradiol—prostate cancer	0.000986	0.00128	CcSEcCtD
Vildagliptin—Dermatitis bullous—Doxorubicin—prostate cancer	0.000979	0.00127	CcSEcCtD
Vildagliptin—Constipation—Estradiol—prostate cancer	0.000978	0.00127	CcSEcCtD
Vildagliptin—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000978	0.00127	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000971	0.00126	CcSEcCtD
Vildagliptin—Hypoglycaemia—Doxorubicin—prostate cancer	0.000959	0.00125	CcSEcCtD
Vildagliptin—Dizziness—Goserelin—prostate cancer	0.000954	0.00124	CcSEcCtD
Vildagliptin—Dizziness—Conjugated Estrogens—prostate cancer	0.000945	0.00123	CcSEcCtD
Vildagliptin—Angiopathy—Docetaxel—prostate cancer	0.000941	0.00122	CcSEcCtD
Vildagliptin—Liver function test abnormal—Epirubicin—prostate cancer	0.000933	0.00121	CcSEcCtD
Vildagliptin—Chills—Docetaxel—prostate cancer	0.00093	0.00121	CcSEcCtD
Vildagliptin—Fatigue—Mitoxantrone—prostate cancer	0.000919	0.00119	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000918	0.00119	CcSEcCtD
Vildagliptin—Constipation—Mitoxantrone—prostate cancer	0.000911	0.00118	CcSEcCtD
Vildagliptin—Angiopathy—Capecitabine—prostate cancer	0.000911	0.00118	CcSEcCtD
Vildagliptin—Urticaria—Estradiol—prostate cancer	0.000909	0.00118	CcSEcCtD
Vildagliptin—Nasopharyngitis—Epirubicin—prostate cancer	0.000904	0.00117	CcSEcCtD
Vildagliptin—Headache—Goserelin—prostate cancer	0.000904	0.00117	CcSEcCtD
Vildagliptin—Malnutrition—Docetaxel—prostate cancer	0.000903	0.00117	CcSEcCtD
Vildagliptin—Chills—Capecitabine—prostate cancer	0.000901	0.00117	CcSEcCtD
Vildagliptin—Headache—Conjugated Estrogens—prostate cancer	0.000895	0.00116	CcSEcCtD
Vildagliptin—Infection—Etoposide—prostate cancer	0.000881	0.00114	CcSEcCtD
Vildagliptin—Connective tissue disorder—Prednisone—prostate cancer	0.000879	0.00114	CcSEcCtD
Vildagliptin—Malnutrition—Capecitabine—prostate cancer	0.000874	0.00114	CcSEcCtD
Vildagliptin—Liver function test abnormal—Doxorubicin—prostate cancer	0.000864	0.00112	CcSEcCtD
Vildagliptin—Flatulence—Capecitabine—prostate cancer	0.000861	0.00112	CcSEcCtD
Vildagliptin—Skin disorder—Etoposide—prostate cancer	0.000861	0.00112	CcSEcCtD
Vildagliptin—Nausea—Goserelin—prostate cancer	0.000857	0.00111	CcSEcCtD
Vildagliptin—Hyperhidrosis—Etoposide—prostate cancer	0.000857	0.00111	CcSEcCtD
Vildagliptin—Pancreatitis—Epirubicin—prostate cancer	0.000857	0.00111	CcSEcCtD
Vildagliptin—Nausea—Conjugated Estrogens—prostate cancer	0.000849	0.0011	CcSEcCtD
Vildagliptin—Urticaria—Mitoxantrone—prostate cancer	0.000847	0.0011	CcSEcCtD
Vildagliptin—Nasopharyngitis—Doxorubicin—prostate cancer	0.000837	0.00109	CcSEcCtD
Vildagliptin—Asthenia—Estradiol—prostate cancer	0.000821	0.00107	CcSEcCtD
Vildagliptin—Tremor—Capecitabine—prostate cancer	0.000819	0.00106	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000812	0.00106	CcSEcCtD
Vildagliptin—Angiopathy—Prednisone—prostate cancer	0.000811	0.00105	CcSEcCtD
Vildagliptin—Weight increased—Epirubicin—prostate cancer	0.000795	0.00103	CcSEcCtD
Vildagliptin—Pancreatitis—Doxorubicin—prostate cancer	0.000793	0.00103	CcSEcCtD
Vildagliptin—Diarrhoea—Estradiol—prostate cancer	0.000783	0.00102	CcSEcCtD
Vildagliptin—Infestation NOS—Epirubicin—prostate cancer	0.000779	0.00101	CcSEcCtD
Vildagliptin—Infestation—Epirubicin—prostate cancer	0.000779	0.00101	CcSEcCtD
Vildagliptin—Malnutrition—Prednisone—prostate cancer	0.000779	0.00101	CcSEcCtD
Vildagliptin—Arthralgia—Docetaxel—prostate cancer	0.000769	0.000998	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Etoposide—prostate cancer	0.000765	0.000994	CcSEcCtD
Vildagliptin—Asthenia—Mitoxantrone—prostate cancer	0.000765	0.000993	CcSEcCtD
Vildagliptin—Fatigue—Etoposide—prostate cancer	0.000764	0.000993	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000763	0.000991	CcSEcCtD
Vildagliptin—Constipation—Etoposide—prostate cancer	0.000758	0.000985	CcSEcCtD
Vildagliptin—Dizziness—Estradiol—prostate cancer	0.000756	0.000983	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000751	0.000976	CcSEcCtD
Vildagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—LEP—prostate cancer	0.000749	0.053	CbGpPWpGaD
Vildagliptin—Arthralgia—Capecitabine—prostate cancer	0.000744	0.000967	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000739	0.00096	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Epirubicin—prostate cancer	0.000737	0.000957	CcSEcCtD
Vildagliptin—Oedema—Docetaxel—prostate cancer	0.000737	0.000957	CcSEcCtD
Vildagliptin—Weight increased—Doxorubicin—prostate cancer	0.000736	0.000956	CcSEcCtD
Vildagliptin—Infection—Docetaxel—prostate cancer	0.000732	0.000951	CcSEcCtD
Vildagliptin—Diarrhoea—Mitoxantrone—prostate cancer	0.000729	0.000947	CcSEcCtD
Vildagliptin—Nervous system disorder—Docetaxel—prostate cancer	0.000723	0.000939	CcSEcCtD
Vildagliptin—Infestation—Doxorubicin—prostate cancer	0.000721	0.000937	CcSEcCtD
Vildagliptin—Infestation NOS—Doxorubicin—prostate cancer	0.000721	0.000937	CcSEcCtD
Vildagliptin—Headache—Estradiol—prostate cancer	0.000717	0.000931	CcSEcCtD
Vildagliptin—Skin disorder—Docetaxel—prostate cancer	0.000716	0.00093	CcSEcCtD
Vildagliptin—Oedema—Capecitabine—prostate cancer	0.000713	0.000927	CcSEcCtD
Vildagliptin—Angioedema—Prednisone—prostate cancer	0.000711	0.000924	CcSEcCtD
Vildagliptin—Infection—Capecitabine—prostate cancer	0.000709	0.000921	CcSEcCtD
Vildagliptin—Urticaria—Etoposide—prostate cancer	0.000704	0.000915	CcSEcCtD
Vildagliptin—Nervous system disorder—Capecitabine—prostate cancer	0.0007	0.000909	CcSEcCtD
Vildagliptin—Hepatitis—Epirubicin—prostate cancer	0.000699	0.000909	CcSEcCtD
Vildagliptin—Skin disorder—Capecitabine—prostate cancer	0.000693	0.0009	CcSEcCtD
Vildagliptin—Hyperhidrosis—Capecitabine—prostate cancer	0.00069	0.000896	CcSEcCtD
Vildagliptin—Oedema peripheral—Epirubicin—prostate cancer	0.000689	0.000895	CcSEcCtD
Vildagliptin—Connective tissue disorder—Epirubicin—prostate cancer	0.000687	0.000893	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000682	0.000886	CcSEcCtD
Vildagliptin—Nausea—Estradiol—prostate cancer	0.000679	0.000883	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000671	0.000872	CcSEcCtD
Vildagliptin—Headache—Mitoxantrone—prostate cancer	0.000668	0.000867	CcSEcCtD
Vildagliptin—DPP4—Incretin synthesis, secretion, and inactivation—LEP—prostate cancer	0.000666	0.0471	CbGpPWpGaD
Vildagliptin—Arthralgia—Prednisone—prostate cancer	0.000663	0.000861	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000658	0.000855	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.00065	0.000844	CcSEcCtD
Vildagliptin—Hepatitis—Doxorubicin—prostate cancer	0.000647	0.000841	CcSEcCtD
Vildagliptin—Oedema peripheral—Doxorubicin—prostate cancer	0.000638	0.000828	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000636	0.000826	CcSEcCtD
Vildagliptin—Asthenia—Etoposide—prostate cancer	0.000636	0.000826	CcSEcCtD
Vildagliptin—Connective tissue disorder—Doxorubicin—prostate cancer	0.000636	0.000826	CcSEcCtD
Vildagliptin—Oedema—Prednisone—prostate cancer	0.000635	0.000825	CcSEcCtD
Vildagliptin—Fatigue—Docetaxel—prostate cancer	0.000635	0.000825	CcSEcCtD
Vildagliptin—Angiopathy—Epirubicin—prostate cancer	0.000635	0.000824	CcSEcCtD
Vildagliptin—Nausea—Mitoxantrone—prostate cancer	0.000633	0.000822	CcSEcCtD
Vildagliptin—Infection—Prednisone—prostate cancer	0.000631	0.00082	CcSEcCtD
Vildagliptin—Constipation—Docetaxel—prostate cancer	0.00063	0.000818	CcSEcCtD
Vildagliptin—Chills—Epirubicin—prostate cancer	0.000628	0.000815	CcSEcCtD
Vildagliptin—Nervous system disorder—Prednisone—prostate cancer	0.000623	0.000809	CcSEcCtD
Vildagliptin—Skin disorder—Prednisone—prostate cancer	0.000617	0.000802	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000616	0.0008	CcSEcCtD
Vildagliptin—Fatigue—Capecitabine—prostate cancer	0.000615	0.000799	CcSEcCtD
Vildagliptin—Hyperhidrosis—Prednisone—prostate cancer	0.000614	0.000798	CcSEcCtD
Vildagliptin—Constipation—Capecitabine—prostate cancer	0.00061	0.000792	CcSEcCtD
Vildagliptin—Malnutrition—Epirubicin—prostate cancer	0.000609	0.000791	CcSEcCtD
Vildagliptin—Diarrhoea—Etoposide—prostate cancer	0.000607	0.000788	CcSEcCtD
Vildagliptin—Flatulence—Epirubicin—prostate cancer	0.0006	0.000779	CcSEcCtD
Vildagliptin—Angiopathy—Doxorubicin—prostate cancer	0.000587	0.000763	CcSEcCtD
Vildagliptin—Dizziness—Etoposide—prostate cancer	0.000586	0.000762	CcSEcCtD
Vildagliptin—Chills—Doxorubicin—prostate cancer	0.000581	0.000754	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000579	0.000752	CcSEcCtD
Vildagliptin—Urticaria—Capecitabine—prostate cancer	0.000567	0.000736	CcSEcCtD
Vildagliptin—Malnutrition—Doxorubicin—prostate cancer	0.000563	0.000732	CcSEcCtD
Vildagliptin—DPP4—Peptide hormone metabolism—MME—prostate cancer	0.000563	0.0398	CbGpPWpGaD
Vildagliptin—Headache—Etoposide—prostate cancer	0.000555	0.000721	CcSEcCtD
Vildagliptin—Flatulence—Doxorubicin—prostate cancer	0.000555	0.000721	CcSEcCtD
Vildagliptin—Fatigue—Prednisone—prostate cancer	0.000548	0.000712	CcSEcCtD
Vildagliptin—Constipation—Prednisone—prostate cancer	0.000543	0.000706	CcSEcCtD
Vildagliptin—DPP4—Peptide hormone metabolism—GRP—prostate cancer	0.000539	0.0381	CbGpPWpGaD
Vildagliptin—Asthenia—Docetaxel—prostate cancer	0.000529	0.000687	CcSEcCtD
Vildagliptin—Nausea—Etoposide—prostate cancer	0.000527	0.000684	CcSEcCtD
Vildagliptin—Arthralgia—Epirubicin—prostate cancer	0.000518	0.000673	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000515	0.000669	CcSEcCtD
Vildagliptin—Asthenia—Capecitabine—prostate cancer	0.000512	0.000665	CcSEcCtD
Vildagliptin—Urticaria—Prednisone—prostate cancer	0.000505	0.000656	CcSEcCtD
Vildagliptin—Diarrhoea—Docetaxel—prostate cancer	0.000504	0.000655	CcSEcCtD
Vildagliptin—Oedema—Epirubicin—prostate cancer	0.000497	0.000646	CcSEcCtD
Vildagliptin—Infection—Epirubicin—prostate cancer	0.000494	0.000641	CcSEcCtD
Vildagliptin—Diarrhoea—Capecitabine—prostate cancer	0.000488	0.000634	CcSEcCtD
Vildagliptin—Nervous system disorder—Epirubicin—prostate cancer	0.000487	0.000633	CcSEcCtD
Vildagliptin—Dizziness—Docetaxel—prostate cancer	0.000487	0.000633	CcSEcCtD
Vildagliptin—Skin disorder—Epirubicin—prostate cancer	0.000483	0.000627	CcSEcCtD
Vildagliptin—Hyperhidrosis—Epirubicin—prostate cancer	0.00048	0.000624	CcSEcCtD
Vildagliptin—Arthralgia—Doxorubicin—prostate cancer	0.00048	0.000623	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000476	0.000619	CcSEcCtD
Vildagliptin—Dizziness—Capecitabine—prostate cancer	0.000472	0.000613	CcSEcCtD
Vildagliptin—Headache—Docetaxel—prostate cancer	0.000462	0.0006	CcSEcCtD
Vildagliptin—Oedema—Doxorubicin—prostate cancer	0.00046	0.000597	CcSEcCtD
Vildagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—prostate cancer	0.000459	0.0325	CbGpPWpGaD
Vildagliptin—Infection—Doxorubicin—prostate cancer	0.000457	0.000593	CcSEcCtD
Vildagliptin—Asthenia—Prednisone—prostate cancer	0.000456	0.000592	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000453	0.000588	CcSEcCtD
Vildagliptin—Nervous system disorder—Doxorubicin—prostate cancer	0.000451	0.000586	CcSEcCtD
Vildagliptin—Headache—Capecitabine—prostate cancer	0.000447	0.00058	CcSEcCtD
Vildagliptin—Skin disorder—Doxorubicin—prostate cancer	0.000447	0.00058	CcSEcCtD
Vildagliptin—Hyperhidrosis—Doxorubicin—prostate cancer	0.000445	0.000577	CcSEcCtD
Vildagliptin—Nausea—Docetaxel—prostate cancer	0.000438	0.000568	CcSEcCtD
Vildagliptin—Diarrhoea—Prednisone—prostate cancer	0.000435	0.000565	CcSEcCtD
Vildagliptin—DPP4—Peptide hormone metabolism—ACHE—prostate cancer	0.000431	0.0305	CbGpPWpGaD
Vildagliptin—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000429	0.000557	CcSEcCtD
Vildagliptin—Fatigue—Epirubicin—prostate cancer	0.000428	0.000557	CcSEcCtD
Vildagliptin—Constipation—Epirubicin—prostate cancer	0.000425	0.000552	CcSEcCtD
Vildagliptin—Nausea—Capecitabine—prostate cancer	0.000424	0.00055	CcSEcCtD
Vildagliptin—Dizziness—Prednisone—prostate cancer	0.00042	0.000546	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000419	0.000544	CcSEcCtD
Vildagliptin—DPP4—Incretin synthesis, secretion, and inactivation—CTNNB1—prostate cancer	0.000409	0.0289	CbGpPWpGaD
Vildagliptin—DPP4—Peptide hormone metabolism—CTSD—prostate cancer	0.000408	0.0289	CbGpPWpGaD
Vildagliptin—Headache—Prednisone—prostate cancer	0.000398	0.000517	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000397	0.000516	CcSEcCtD
Vildagliptin—Fatigue—Doxorubicin—prostate cancer	0.000396	0.000515	CcSEcCtD
Vildagliptin—Urticaria—Epirubicin—prostate cancer	0.000395	0.000513	CcSEcCtD
Vildagliptin—Constipation—Doxorubicin—prostate cancer	0.000393	0.000511	CcSEcCtD
Vildagliptin—Nausea—Prednisone—prostate cancer	0.000377	0.00049	CcSEcCtD
Vildagliptin—Urticaria—Doxorubicin—prostate cancer	0.000365	0.000474	CcSEcCtD
Vildagliptin—DPP4—Peptide hormone metabolism—ACE—prostate cancer	0.000364	0.0257	CbGpPWpGaD
Vildagliptin—Asthenia—Epirubicin—prostate cancer	0.000357	0.000463	CcSEcCtD
Vildagliptin—Diarrhoea—Epirubicin—prostate cancer	0.00034	0.000442	CcSEcCtD
Vildagliptin—Asthenia—Doxorubicin—prostate cancer	0.00033	0.000429	CcSEcCtD
Vildagliptin—Dizziness—Epirubicin—prostate cancer	0.000329	0.000427	CcSEcCtD
Vildagliptin—Diarrhoea—Doxorubicin—prostate cancer	0.000315	0.000409	CcSEcCtD
Vildagliptin—Headache—Epirubicin—prostate cancer	0.000311	0.000404	CcSEcCtD
Vildagliptin—Dizziness—Doxorubicin—prostate cancer	0.000304	0.000395	CcSEcCtD
Vildagliptin—Nausea—Epirubicin—prostate cancer	0.000295	0.000383	CcSEcCtD
Vildagliptin—Headache—Doxorubicin—prostate cancer	0.000288	0.000374	CcSEcCtD
Vildagliptin—DPP4—Metabolism of proteins—IGFBP6—prostate cancer	0.000284	0.0201	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—TUSC3—prostate cancer	0.000284	0.0201	CbGpPWpGaD
Vildagliptin—Nausea—Doxorubicin—prostate cancer	0.000273	0.000355	CcSEcCtD
Vildagliptin—DPP4—Metabolism of proteins—SSR2—prostate cancer	0.000253	0.0179	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—GALNT3—prostate cancer	0.000253	0.0179	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—SPON2—prostate cancer	0.000231	0.0163	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—HERPUD1—prostate cancer	0.000231	0.0163	CbGpPWpGaD
Vildagliptin—DPP4—Peptide hormone metabolism—LEP—prostate cancer	0.000226	0.016	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—KLK3—prostate cancer	0.000215	0.0152	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—MBTPS1—prostate cancer	0.000202	0.0143	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—RPN2—prostate cancer	0.000202	0.0143	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—KLK2—prostate cancer	0.000202	0.0143	CbGpPWpGaD
Vildagliptin—DPP4—Peptide hormone metabolism—INS—prostate cancer	0.000193	0.0136	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—TCP1—prostate cancer	0.000192	0.0135	CbGpPWpGaD
Vildagliptin—DPP4—Peptide hormone metabolism—IGF1—prostate cancer	0.000187	0.0132	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—DNAJC3—prostate cancer	0.000183	0.0129	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—GCNT1—prostate cancer	0.000175	0.0124	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—PDIA3—prostate cancer	0.000169	0.0119	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—EIF3H—prostate cancer	0.000163	0.0115	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—TPP1—prostate cancer	0.000163	0.0115	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—B4GALT4—prostate cancer	0.000163	0.0115	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—F9—prostate cancer	0.000158	0.0112	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—MUC4—prostate cancer	0.000149	0.0105	CbGpPWpGaD
Vildagliptin—DPP4—Peptide hormone metabolism—CTNNB1—prostate cancer	0.000139	0.00979	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—RPL12—prostate cancer	0.00013	0.00921	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—HSP90B1—prostate cancer	0.000124	0.00873	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—EIF3A—prostate cancer	0.00012	0.00845	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—MME—prostate cancer	0.000106	0.00751	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—GRP—prostate cancer	0.000102	0.00719	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—RPL10—prostate cancer	9.87e-05	0.00698	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—ATF3—prostate cancer	8.86e-05	0.00626	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—IGFBP3—prostate cancer	8.34e-05	0.0059	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—ACHE—prostate cancer	8.14e-05	0.00575	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—RPS19—prostate cancer	7.83e-05	0.00553	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—CTSD—prostate cancer	7.71e-05	0.00545	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—THBS1—prostate cancer	7.59e-05	0.00537	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—CALR—prostate cancer	7.22e-05	0.0051	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—ACE—prostate cancer	6.87e-05	0.00486	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—PLAUR—prostate cancer	6.17e-05	0.00436	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—LEP—prostate cancer	4.27e-05	0.00302	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—INS—prostate cancer	3.65e-05	0.00258	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—IGF1—prostate cancer	3.53e-05	0.00249	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—MMP2—prostate cancer	3.41e-05	0.00241	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—CXCL8—prostate cancer	2.84e-05	0.002	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—CTNNB1—prostate cancer	2.62e-05	0.00185	CbGpPWpGaD
